These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1837724)

  • 21. Cross-presentation of HLA class I epitopes from exogenous NY-ESO-1 polypeptides by nonprofessional APCs.
    Gnjatic S; Atanackovic D; Matsuo M; Jäger E; Lee SY; Valmori D; Chen YT; Ritter G; Knuth A; Old LJ
    J Immunol; 2003 Feb; 170(3):1191-6. PubMed ID: 12538675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
    Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
    PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen processing for presentation by MHC class I molecules.
    Braciale TJ
    Curr Opin Immunol; 1992 Feb; 4(1):59-62. PubMed ID: 1596368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.
    Braciale TJ; Morrison LA; Sweetser MT; Sambrook J; Gething MJ; Braciale VL
    Immunol Rev; 1987 Aug; 98():95-114. PubMed ID: 2443444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific suppression of human CD4+ Th cell responses to pig MHC antigens by CD8+CD28- regulatory T cells.
    Ciubotariu R; Colovai AI; Pennesi G; Liu Z; Smith D; Berlocco P; Cortesini R; Suciu-Foca N
    J Immunol; 1998 Nov; 161(10):5193-202. PubMed ID: 9820490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accessory proteins that control the assembly of MHC molecules with peptides.
    Van Kaer L
    Immunol Res; 2001; 23(2-3):205-14. PubMed ID: 11444385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antigen unfolding and disulfide reduction in antigen presenting cells.
    Jensen PE
    Semin Immunol; 1995 Dec; 7(6):347-53. PubMed ID: 8775460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Presentation of a self-peptide for in vivo tolerance induction of CD4+ T cells is governed by a processing factor that maps to the class II region of the major histocompatibility complex locus.
    Fedoseyeva EV; Tam RC; Orr PL; Garovoy MR; Benichou G
    J Exp Med; 1995 Nov; 182(5):1481-91. PubMed ID: 7595218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Processing of a minimal antigenic peptide alters its interaction with MHC molecules.
    Fox BS; Carbone FR; Germain RN; Paterson Y; Schwartz RH
    Nature; 1988 Feb; 331(6156):538-40. PubMed ID: 2448649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular studies on antigen presentation by class II MHC molecules.
    Unanue ER
    Curr Opin Immunol; 1992 Feb; 4(1):63-9. PubMed ID: 1596369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cysteinylation of MHC class II ligands: peptide endocytosis and reduction within APC influences T cell recognition.
    Haque MA; Hawes JW; Blum JS
    J Immunol; 2001 Apr; 166(7):4543-51. PubMed ID: 11254711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mechanisms of lipid antigen presentation by CD1.
    Jackman RM; Moody DB; Porcelli SA
    Crit Rev Immunol; 1999; 19(1):49-63. PubMed ID: 9987600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
    Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
    J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen processing for presentation to CD4+ T cells.
    Long EO
    New Biol; 1992 Apr; 4(4):274-82. PubMed ID: 1535789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosynthesis of major histocompatibility complex molecules and generation of T cells in Ii TAP1 double-mutant mice.
    Tourne S; van Santen HM; van Roon M; Berns A; Benoist C; Mathis D; Ploegh H
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1464-9. PubMed ID: 8643655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antigen presentation: structural themes and functional variations.
    Braciale TJ; Braciale VL
    Immunol Today; 1991 Apr; 12(4):124-9. PubMed ID: 1711855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular colocalization of molecules involved in antigen processing and presentation by B cells.
    Brodsky FM; Koppelman B; Blum JS; Marks MS; Cresswell P; Guagliardi L
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():319-31. PubMed ID: 2700939
    [No Abstract]   [Full Text] [Related]  

  • 38. Antigen processing and presentation in the thymus: implications for T cell repertoire selection.
    Kondo K; Takada K; Takahama Y
    Curr Opin Immunol; 2017 Jun; 46():53-57. PubMed ID: 28477557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collective Genetic Interaction Effects and the Role of Antigen-Presenting Cells in Autoimmune Diseases.
    Woo HJ; Yu C; Reifman J
    PLoS One; 2017; 12(1):e0169918. PubMed ID: 28081217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The peptidic self model: a reassessment of the role of the major histocompatibility complex molecules in the restriction of the T-cell response.
    Claverie JM; Kourilsky P
    Ann Inst Pasteur Immunol; 1986; 137D(3):425-42. PubMed ID: 3103648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.